Home › Osteosarcoma › Colorado › Aurora
Osteosarcoma clinical trials in Aurora, CO
6 studies for Osteosarcoma are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
RecruitingPhase 1
- Children's Hospital Colorado, Aurora
Losartan + Sunitinib in Treatment of Osteosarcoma
RecruitingPhase 1
- Children's Hospital Colorado, Aurora
- University of Colorado Hospital, Aurora
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
RecruitingPhase 1/2
- Children's Hospital Colorado, Aurora
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RecruitingPhase 3
- Children's Hospital Colorado, Aurora
Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
RecruitingPhase 1/2
- Children's Hospital Colorado, Aurora
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RecruitingPhase 2
- Children's Hospital of Colorado, Aurora
Osteosarcoma trials in other cities
- St. Louis, MO10 studies
- Memphis, TN10 studies
- Atlanta, GA10 studies
- Boston, MA9 studies
- Houston, TX9 studies
- Birmingham, AL7 studies
- Cincinnati, OH7 studies
- Mountain View, CA7 studies
- Los Angeles, CA7 studies
- Chicago, IL7 studies
- Dallas, TX6 studies
- Tampa, FL6 studies
Other studies in Aurora
- Cancer (all types)34 studies
- Colorectal Cancer33 studies
- Non-Small Cell Lung Cancer31 studies
- Breast Cancer30 studies
- Type 1 Diabetes26 studies
- Metastatic Cancer24 studies
- Ovarian Cancer23 studies
- Obesity20 studies
- Lung Cancer19 studies
- Melanoma18 studies
- Heart Failure17 studies
- Prostate Cancer17 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.